Antithrombin Market Size, Share, Trends, Growth and Forecast 2032

Antithrombin Market Insights

According to Zion Market Research, the global Antithrombin Market was worth USD 617.08 Million in 2023. The market is forecast to reach USD 934.57 Million by 2032, growing at a compound annual growth rate (CAGR) of 4.72% during the forecast period 2024-2032.

The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Antithrombin Market industry over the next decade.

Request Free Sample

Market Overview    

Antithrombin is a protein present in the blood stream, which functions as a naturally occurring mild blood thinner. Antithrombin helps to control too much clotting. A person with low antithrombin levels has more tendency to clot more easily. Vice-versa, if antithrombin levels are too high, a person could, theoretically, have a more bleeding tendency. However, raised levels of antithrombin do not appear to cause bleeding or have any clinical significance.

Antithrombin is a serpin which is similar in structure to most other plasma protease inhibitors. According to the report published by U.S. Department of health & human services in 2018, Antithrombin deficiency is expected to occur in about 1 in 2000 people across the globe.

Request Free Sample

COVID-19 Impact Analysis:

The Covid-19 has positively impacted on the growth of the Antithrombin market. As the Antithrombin is a protein which helps to regulate blood clot formation. Due to corona virus spread in the community, the protein level and immunity of the people drop due to severe attack of virus. In order to increase the protein level, the Antithrombin plays important role prevention of blood clotting as it acts as a natural blood thinner and extensively used while performing surgical procedures in the patient with low antithrombic levels. However, the world markets are slowly opening to their full potential and theirs a surge in demand of Antithrombin is likely to increase in the coming years. The market would remain bullish in upcoming year.   

Growth Factors

The widespread use of antithrombin for the treatment of various medical conditions such as extracorporeal membrane oxygenation, hereditary antithrombin deficiency, sepsis, and disseminated intravascular coagulation are the major factors responsible for the growth of global antithrombin market. Moreover, the rising adoption of antithrombin as a combination therapy with heparin is expected to open huge growth opportunities for antithrombin market.

Antithrombin Market: Report Scope

Source Segment Analysis Preview

By source, the antithrombin market has been segmented as human, and goat milk. The human source, the segment is estimated to account major shares in global antithrombin market in 2016. Humans are the major source of antithrombins, but know a day’s the use of goat milk for the production of antithrombin is increasing. Goats produce about 800 liters of milk per year. As compared to cell culture model, the yield of the active protein by goat model is 10 times more. The transgenic goats are the excellent source for antithrombin production, as they produce plenty of milk in short generation time, and these factors are responsible for the high growth of goat milk segment over the forecast period. Currently, the goat milk produced antithrombins are available in developed countries such as U.S., UK, and Germany etc. The increasing adoption of newer technologies and advanced products in developing countries is expected to drive the growth of segment over the forecast period.

On the basis of application, the global antithrombin market is segmented into major three types such as diagnostics, therapeutics, and research.

By application, the therapeutics segment is estimated to account major share in global antithrombin market. The increasing research and development activities and rising government initiatives for research are expected to drive the growth of research segment globally.

On the basis of the dosage form, the global antithrombin market is segmented as a liquid and lyophilized.

The lyophilized dosage form accounted major share in the global market in 2016 and expected to register high CAGR. Lyophilized antithrombins have good self-life, easy to handle and, have wide application and these factors are expected to propel the growth of segment over the forecast period.

Request Free Sample

Key Market Players & Competitive Landscape

Some of the key players in global Antithrombin market include-

• Grifols
• rEVO Biologics Inc.
• Shire plc.
• Kedrion S.p.A.
• CSL Limited
• Scripps Laboratories Inc.
• Lee Biosolutions among others.

Request Free Sample

The global Antithrombin market is segmented as follows:   

By Source

• Human
• Goat Milk

By Application

• Diagnostics
• Therapeutics
• Research

By Dosage Form

• Liquid
• Lyophilized

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa